Toxicity may be more likely among patients on chronic valproic acid who already have a baseline elevated level
A 14% DROP IN CARDIOVASCULAR RISK The SOUL trial, published in the New England Journal of Medicine, followed 9,650 adults with type 2 diabetes and high cardiovascular risk for nearly four years
Understanding what glycine does, and why compounding pharmacies add it, puts you in a fundamentally better position to evaluate your treatment options and get the most from your protocol
These specialists integrate GLP-1 receptor agonists into thorough weight loss programs that combine medical intervention with lifestyle changes
In his review of this history, Klatt points to two bellwether moments President Eisenhowers heart attack in 1955 and a 1961 Time Magazine cover warning of the dangers of fat intake and heart disease that alerted Americans to the prevalence of cardiovascular disease as a new threat facing Americans, as the risk of death from infectious disease waned